National Center for Advancing Translational Sciences; Notice of Closed Meetings, 52803-52804 [2022-18530]

Download as PDF Federal Register / Vol. 87, No. 166 / Monday, August 29, 2022 / Notices business or professional affiliation of the interested person. Information is also available on the Institute’s/Center’s home page: https:// orwh.od.nih.gov/, where an agenda and any additional information for the meeting will be posted when available. Dated: August 22, 2022. Lauren K. Roth, Associate Commissioner for Policy. [FR Doc. 2022–18521 Filed 8–26–22; 8:45 am] BILLING CODE 4164–01–P DEPARTMENT OF HEALTH AND HUMAN SERVICES National Institutes of Health Office of the Director, National Institutes of Health; Notice of Meeting khammond on DSKJM1Z7X2PROD with NOTICES Pursuant to section 10(a) of the Federal Advisory Committee Act, as amended, notice is hereby given of a meeting of the Advisory Committee on Research on Women’s Health. The meeting will be held as a virtual meeting and open to the public. Individuals who plan to view the virtual meeting and need special assistance or other reasonable accommodations to view the meeting, should notify the Contact Person listed below in advance of the meeting. The meeting will be videocast and can be accessed from the NIH Videocasting and Podcasting website (https://videocast.nih.gov/). Name of Committee: Advisory Committee on Research on Women’s Health. Date: October 18, 2022. Time: 9:30 a.m. to 4:00 p.m. Agenda: ORWH Director’s Report; Presentation from the Director of the National Institute of Environmental Health Sciences (NIEHS); Panel discussing the environmental effects on the health of women; Presentation on the content areas for the FY2024–2028 Strategic Plan on Research on the Health of Women; e-Learning course demonstration; and ORWH concept clearance. Place: National Institutes of Health, 6701 Rockledge Drive, Bethesda, MD 20892, (Virtual Meeting). Contact Person: Samia Noursi, Ph.D., Associate Director, Science Policy, Planning, and Analysis, Office of Research on Women’s Health, National Institutes of Health, 6707 Democracy Blvd., Room 402, Bethesda, MD 20892, 301–496–9472 samia.noursi@nih.gov. Any member of the public interested in presenting oral comments to the committee may notify the Contact Person listed on this notice at least 10 days in advance of the meetings. Interested individuals and representatives of organizations may submit a letter of intent, a brief description of the organization represented, and a short description of the oral presentation. Only one representative of an organization may be allowed to present oral comments and if accepted by the committee, presentations may be limited to five minutes. Both printed and electronic copies are requested for the record. In addition, any interested person may file written comments with the committee by forwarding their statement to the Contact Person listed on this notice. The statement should include the name, address, telephone number and when applicable, the VerDate Sep<11>2014 17:01 Aug 26, 2022 Jkt 256001 (Catalogue of Federal Domestic Assistance Program Nos. 93.14, Intramural Research Training Award; 93.22, Clinical Research Loan Repayment Program for Individuals from Disadvantaged Backgrounds; 93.232, Loan Repayment Program for Research Generally; 93.39, Academic Research Enhancement Award; 93.936, NIH Acquired Immunodeficiency Syndrome Research Loan Repayment Program; 93.187, Undergraduate Scholarship Program for Individuals from Disadvantaged Backgrounds, National Institutes of Health, HHS) Dated: August 23, 2022. Miguelina Perez, Program Analyst, Office of Federal Advisory Committee Policy. [FR Doc. 2022–18474 Filed 8–26–22; 8:45 am] BILLING CODE 4140–01–P DEPARTMENT OF HEALTH AND HUMAN SERVICES National Institutes of Health National Institute on Aging; Notice of Closed Meeting Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended, notice is hereby given of the following meeting. The meeting will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., as amended. The grant applications and the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the grant applications, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy. Name of Committee: National Institute on Aging Initial Review Group; Career Development For Early Career Investigators Study Section. Date: October 13–14, 2022. Time: 10:00 a.m. to 6:00 p.m. Agenda: To review and evaluate grant applications. Place: National Institutes of Health, National Institute on Aging, Gateway Building, 7201 Wisconsin Avenue, Bethesda, MD 20892 (Virtual Meeting). Contact Person: Carmen Moten, Ph.D., MPH, Scientific Review Officer, National Institutes of Health, NCI Center to Reduce Cancer Health Disparities, 6116 Executive Boulevard, Suite 602, Bethesda, MD 20892, 301–496–8589, CMOTEN@MAIL.NIH.GOV. PO 00000 Frm 00067 Fmt 4703 Sfmt 4703 52803 Information is also available on the Institute’s/Center’s home page: www.nia.nih.gov/, where an agenda and any additional information for the meeting will be posted when available. (Catalogue of Federal Domestic Assistance Program Nos. 93.866, Aging Research, National Institutes of Health, HHS) Dated: August 23, 2022, Miguelina Perez, Program Analyst, Office of Federal Advisory Committee Policy. [FR Doc. 2022–18477 Filed 8–26–22; 8:45 am] BILLING CODE 4140–01–P DEPARTMENT OF HEALTH AND HUMAN SERVICES National Institutes of Health National Center for Advancing Translational Sciences; Notice of Closed Meetings Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended, notice is hereby given of the following meetings. The meetings will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., as amended. The grant applications and the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the grant applications, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy. Name of Committee: National Center for Advancing Translational Sciences Special Emphasis Panel; CTSA Training Grants Review. Date: September 13–14, 2022. Time: 10 a.m. to 6 p.m. Agenda: To review and evaluate grant applications. Place: National Center for Advancing Translational Sciences, National Institutes of Health, 6701 Democracy Boulevard, Suite 1037, Bethesda, MD 20892 (Virtual Meeting). Contact Person: Carol (Chang-Sook) Kim, Ph.D., Scientific Review Administrator, Office of Grants Management and Scientific Review, National Center for Advancing Translational Sciences, National Institutes of Health, 6701 Democracy Boulevard, Suite 1037, Bethesda, MD 20892, (301) 402–1744, carolko@mail.nih.gov. Name of Committee: National Center for Advancing Translational Sciences Special Emphasis Panel; CTSA Resource Center Review. Date: October 14, 2022. Time: 10 a.m. to 3 p.m. Agenda: To review and evaluate grant applications. Place: National Center for Advancing Translational Sciences, National Institutes of E:\FR\FM\29AUN1.SGM 29AUN1 52804 Federal Register / Vol. 87, No. 166 / Monday, August 29, 2022 / Notices Health, 6701 Democracy Boulevard, Suite 1037, Bethesda, MD 20892 (Virtual Meeting). Contact Person: Jing Chen, Ph.D., Scientific Review Officer, Office of Scientific Review, National Center for Advancing Translational Sciences, National Institutes of Health, 6701 Democracy Boulevard, Suite 1037, Bethesda, MD 20892, chenjing@mail.nih.gov, (301) 827–3268. (Catalogue of Federal Domestic Assistance Program Nos. 93.859, Pharmacology, Physiology, and Biological Chemistry Research; 93.350, B—Cooperative Agreements; 93.859, Biomedical Research and Research Training, National Institutes of Health, HHS) Dated: August 24, 2022. Melanie J. Pantoja, Program Analyst, Office of Federal Advisory Committee Policy. [FR Doc. 2022–18530 Filed 8–26–22; 8:45 am] BILLING CODE 4140–01–P Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended, notice is hereby given of the following meeting. The meeting will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., as amended. The grant applications and the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the grant applications, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy. khammond on DSKJM1Z7X2PROD with NOTICES BILLING CODE 4140–01–P Name of Committee: National Center for Advancing Translational Sciences Special Emphasis Panel; NCATS CTSA UM1 Review Special Emphasis Panel. Date: September 28–29, 2022. Time: 11:00 a.m. to 5:00 p.m. Agenda: To review and evaluate cooperative agreement applications. Place: National Center for Advancing Translational Sciences, National Institutes of Health, 6701 Democracy Boulevard, Room 1037, Bethesda, MD 20892 (Virtual Meeting). Contact Person: Victor Henriquez, Ph.D., Scientific Review Officer, Office of Scientific Review, National Center for Advancing Translational Sciences, National Institutes of Health, 6701 Democracy Boulevard, Room 1037, Bethesda, MD 20892, (301) 402–4938, henriquv@mail.nih.gov. (Catalogue of Federal Domestic Assistance Program Nos. 93.859, Pharmacology, Physiology, and Biological Chemistry calling the toll-free Federal Relay Service at (800) 877–8339. Copies of available documents submitted to OMB may be obtained from Ms. Pollard. SUPPLEMENTARY INFORMATION: This notice informs the public that HUD is seeking approval from OMB for the information collection described in Section A. A. Overview of Information Collection DEPARTMENT OF HOUSING AND URBAN DEVELOPMENT [Docket No. FR–7056–N–28] 60-Day Notice of Proposed Information Collection: FHA Lender Approval, Annual Renewal, Periodic Updates and Required Reports by FHA Approved Lenders, OMB Control No.: 2502–0005 HUD is seeking approval from the Office of Management and Budget (OMB) for the information collection described below. In accordance with the Paperwork Reduction Act, HUD is requesting comment from all interested parties on the proposed collection of information. The purpose of this notice is to allow for 60 days of public comment. SUMMARY: National Center for Advancing Translational Sciences; Notice of Closed Meeting Jkt 256001 [FR Doc. 2022–18533 Filed 8–26–22; 8:45 am] Office of the Assistant Secretary for Housing—Federal Housing Commissioner, HUD. ACTION: Notice. National Institutes of Health 17:01 Aug 26, 2022 Dated: August 24, 2022. Melanie J. Pantoja, Program Analyst, Office of Federal Advisory Committee Policy. AGENCY: DEPARTMENT OF HEALTH AND HUMAN SERVICES VerDate Sep<11>2014 Research; 93.350, B—Cooperative Agreements; 93.859, Biomedical Research and Research Training, National Institutes of Health, HHS) DATES: Comments Due Date: October 28, 2022. Interested persons are invited to submit comments regarding this proposal. Comments should refer to the proposal by name and/or OMB Control Number and should be sent to: Colette Pollard, Reports Management Officer, REE, Department of Housing and Urban Development, 451 7th Street SW, Room 4176, Washington, DC 20410–5000; telephone 202–402–3400 (this is not a toll-free number) or email at Colette.Pollard@hud.gov for a copy of the proposed forms or other available information. Persons with hearing or speech impairments may access this number through TTY by calling the tollfree Federal Relay Service at (800) 877– 8339. FOR FURTHER INFORMATION CONTACT: Colette Pollard, Reports Management Officer, REE, Department of Housing and Urban Development, 451 7th Street SW, Washington, DC 20410; email Colette Pollard at Colette.Pollard@ hud.gov or telephone 202–402–3400. This is not a toll-free number. Persons with hearing or speech impairments may access this number through TTY by ADDRESSES: PO 00000 Frm 00068 Fmt 4703 Sfmt 4703 Title of Information Collection: FHA Lender Approval, Annual Renewal, Periodic Updates and Required Reports by FHA-Approved Lenders. OMB Approval Number: 2502–0005. OMB Expiration Date: October 31, 2022. Type of Request: Revision. Form Number: Online form, with no corresponding number. Description of the need for the information and proposed use: This revision incorporates the requirements of 2 CFR 25, and 2 CFR 170, requiring all entities currently conducting or seeking to do business with the federal government must have a Unique Entity Identifier (UEI) registered in GSA’s System of Award Management. Collection of the UEI is vital to HUD’s compliance with the Federal Funding Accountability and Transparency Act of 2006 (FFATA) and Digital Accountability and Transparency Act of 2014. Respondents: Estimated Number of Respondents: 2,421. Estimated Number of Responses: 2,430. Frequency of Response: Annual/ Periodic. Average Hours per Response: 1 hour. Total Estimated Burden: 2,421.1 B. Solicitation of Public Comment This notice is soliciting comments from members of the public and affected parties concerning the collection of information described in Section A on the following: (1) Whether the proposed collection of information is necessary for the proper performance of the functions of the agency, including whether the information will have practical utility; (2) The accuracy of the agency’s estimate of the burden of the proposed collection of information; (3) Ways to enhance the quality, utility, and clarity 1 Each year of the 2,421 respondents approximately 9 respondents are expected to not meet all eligibility requirements. These respondents must also submit an ‘‘unable to certify’’ report which requires further review before they may proceed. The result is 2,430 total responses from 2,421 respondents. E:\FR\FM\29AUN1.SGM 29AUN1

Agencies

[Federal Register Volume 87, Number 166 (Monday, August 29, 2022)]
[Notices]
[Pages 52803-52804]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2022-18530]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

National Institutes of Health


National Center for Advancing Translational Sciences; Notice of 
Closed Meetings

    Pursuant to section 10(d) of the Federal Advisory Committee Act, as 
amended, notice is hereby given of the following meetings.
    The meetings will be closed to the public in accordance with the 
provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 
U.S.C., as amended. The grant applications and the discussions could 
disclose confidential trade secrets or commercial property such as 
patentable material, and personal information concerning individuals 
associated with the grant applications, the disclosure of which would 
constitute a clearly unwarranted invasion of personal privacy.

    Name of Committee: National Center for Advancing Translational 
Sciences Special Emphasis Panel; CTSA Training Grants Review.
    Date: September 13-14, 2022.
    Time: 10 a.m. to 6 p.m.
    Agenda: To review and evaluate grant applications.
    Place: National Center for Advancing Translational Sciences, 
National Institutes of Health, 6701 Democracy Boulevard, Suite 1037, 
Bethesda, MD 20892 (Virtual Meeting).
    Contact Person: Carol (Chang-Sook) Kim, Ph.D., Scientific Review 
Administrator, Office of Grants Management and Scientific Review, 
National Center for Advancing Translational Sciences, National 
Institutes of Health, 6701 Democracy Boulevard, Suite 1037, 
Bethesda, MD 20892, (301) 402-1744, [email protected].

    Name of Committee: National Center for Advancing Translational 
Sciences Special Emphasis Panel; CTSA Resource Center Review.
    Date: October 14, 2022.
    Time: 10 a.m. to 3 p.m.
    Agenda: To review and evaluate grant applications.
    Place: National Center for Advancing Translational Sciences, 
National Institutes of

[[Page 52804]]

Health, 6701 Democracy Boulevard, Suite 1037, Bethesda, MD 20892 
(Virtual Meeting).
    Contact Person: Jing Chen, Ph.D., Scientific Review Officer, 
Office of Scientific Review, National Center for Advancing 
Translational Sciences, National Institutes of Health, 6701 
Democracy Boulevard, Suite 1037, Bethesda, MD 20892, 
[email protected], (301) 827-3268.

(Catalogue of Federal Domestic Assistance Program Nos. 93.859, 
Pharmacology, Physiology, and Biological Chemistry Research; 93.350, 
B--Cooperative Agreements; 93.859, Biomedical Research and Research 
Training, National Institutes of Health, HHS)

    Dated: August 24, 2022.
Melanie J. Pantoja,
Program Analyst, Office of Federal Advisory Committee Policy.
[FR Doc. 2022-18530 Filed 8-26-22; 8:45 am]
BILLING CODE 4140-01-P

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.